DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Voyager Therapeutics Q4 EPS $(0.34) May Not Compare To $(0.81) Estimate, Sales $32.674M Beat $10.92M Estimate

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.81) by 58.02 percent. This is a 51.43 percent increase over losses of $(0.7) per share

Benzinga · 03/03/2020 21:02

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.81) by 58.02 percent. This is a 51.43 percent increase over losses of $(0.7) per share from the same period last year. The company reported quarterly sales of $32.674 million which beat the analyst consensus estimate of $10.92 million by 199.21 percent. This is a 1.53K percent increase over sales of $2.008 million the same period last year.